Esophageal squamous cell carcinoma (ESCC) is one of the most aggressive squamous cell
carcinomas and is highly prevalent in Asia. Alcohol and its metabolite, acetaldehyde, are …

The taxanes are an important new class of anticancer agents that exert their cytotoxic effects
through a unique mechanism. Paclitaxel (Taxol), the first taxane in clinical trials, is active …

Cancers originating in the esophagus or esophagogastric junction constitute a major global
health problem. Esophageal cancers are histologically classified as squamous cell …

Gastric cancer is the third leading cause of cancer-related deaths worldwide. Over 95% of
gastric cancers are adenocarcinomas, which are typically classified based on anatomic …

Esophageal cancer is the sixth leading cause of cancer-related deaths worldwide.
Squamous cell carcinoma is the most common histology in Eastern Europe and Asia, and …

Esophageal cancer is the sixth most common cause of cancer deaths worldwide.
Adenocarcinoma is more common in North America and Western European countries …

Background We performed a multi-institutional randomized trial comparing preoperative
chemotherapy followed by surgery with surgery alone for patients with local and operable …

▪ Abstract The taxane class of antimicrotubule anticancer agents is perhaps the most
important addition to the chemotherapeutic armamentarium against cancer over the past …

Systemic treatment of advanced esophageal squamous cell carcinoma (ESCC) mainly
consists of cytotoxic agents, aiming to palliate symptoms and prolong survival. Cisplatin and …

Paclitaxel | Drugs Skip to main content SpringerLink Account Menu Find a journal Publish with
us Track your research Search Cart 1.Home 2.Drugs 3.Article Paclitaxel A Review of its …